Rationale: Recent experiments have shown that pre-trial administrations of
nicotine to rats tested in a 16-arm radial maze attenuated the MK-801-induc
ed deficit in both working and reference memory performance. Memory consoli
dation can be influenced in laboratory animals, by post-training administra
tion of drugs. Objective: In the present study we have investigated the eff
ects on memory consolidation of CD1 mice exerted by: a) the non-competitive
N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 [(+)-5-methyl-10,11
-dihydro-5H-dibenzo-[a,d]cyclo-hepten-5,10-iminemaleate] b) nicotine, and c
) combinations of MK-801 and nicotine. Methods: Different groups of mice we
re injected intraperitoneally (IP) with the single drugs and with their com
binations, immediately after training in a passive avoidance task. Addition
al groups of animals were also injected 2 h post-training with the highest
effective dose of MK-801 (0.3 mg/kg), with the highest effective dose of ni
cotine (0.5 mg/kg) or with the combination of an otherwise ineffective dose
of MK-801 (0.1 mg/kg) with the highest effective dose of nicotine, respect
ively. Their performances were compared with those of mice injected with sa
line, with the vehicle of nicotine and with the other treatment combination
s, respectively Results: The results showed that MK-801 exerted deleterious
effects, while nicotine exerted facilitatory effects on mice performances.
Further, an otherwise ineffective dose of MK-801 (0.1 mg/kg) antagonized t
he facilitatory effects of nicotine (0.25 and 0.5 mg/kg). In the 2 h post-t
raining injected groups the treatments were ineffective, showing that the i
mmediate post-training drug administrations affected memory consolidation p
rocesses. Conclusions: In conclusion, from the present research, it is evid
ent that NMDA glutamate and nicotinic acetylcholine receptor systems intera
ct in modulating memory consolidation in CD1 mice.